Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Connected Inhaler System (CIS) in Uncontrolled Asthma
NCT03380429Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2018
- Primary completion
- Jan 2019
- Countries
- 7
01
Overview
Phase 4, randomised, open-label trial in asthma (5 arms), sponsored by GSK. Primary endpoint: Percentage of ELLIPTA Doses Taken (Daily Adherence) Between Month 4 and Month 6 as Determined by the Maintenance Sensor. Started Jan 2018; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT03380429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03380429.